MYCN is implicated in many pediatric embryonal tumors such as neuroblastoma (NB), rhabdomyosarcoma, medulloblastoma, and more recently in therapy-resistant adult cancers including subtypes of breast cancer and prostate cancers [2,5]. This evidence concerns the gene MYCN and embryonal neoplasm.